MDWD
Price:
$18.34
Market Cap:
$197.82M
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.[Read more]
Industry
Biotechnology
IPO Date
2014-03-20
Stock Exchange
NASDAQ
Ticker
MDWD
According to MediWound Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 1.65. This represents a change of -54.56% compared to the average of 3.63 of the last 4 quarters.
The mean historical Current Ratio of MediWound Ltd. over the last ten years is 6.42. The current 1.65 Current Ratio has changed 2.47% with respect to the historical average. Over the past ten years (40 quarters), MDWD's Current Ratio was at its highest in in the September 2014 quarter at 26.04. The Current Ratio was at its lowest in in the December 2021 quarter at 1.39.
Average
6.42
Median
5.42
Minimum
1.39
Maximum
17.58
Discovering the peaks and valleys of MediWound Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 194.72%
Maximum Annual Current Ratio = 17.58
Minimum Annual Increase = -55.99%
Minimum Annual Current Ratio = 1.39
Year | Current Ratio | Change |
---|---|---|
2023 | 4.59 | 20.70% |
2022 | 3.80 | 172.61% |
2021 | 1.39 | -55.99% |
2020 | 3.17 | -7.73% |
2019 | 3.43 | -48.59% |
2018 | 6.68 | -12.59% |
2017 | 7.64 | 22.32% |
2016 | 6.25 | -35.46% |
2015 | 9.68 | -44.93% |
2014 | 17.58 | 194.72% |
The current Current Ratio of MediWound Ltd. (MDWD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.26
5-year avg
3.28
10-year avg
6.42
MediWound Ltd.’s Current Ratio is less than Foghorn Therapeutics Inc. (5.69), less than Eliem Therapeutics, Inc. (60.41), less than Sutro Biopharma, Inc. (3.41), less than Dyadic International, Inc. (5.39), less than Crinetics Pharmaceuticals, Inc. (16.09), less than Inhibrx Biosciences, Inc. (6.20), less than Merus N.V. (8.32), less than Lyell Immunopharma, Inc. (16.19), less than Kronos Bio, Inc. (8.49), less than Aerovate Therapeutics, Inc. (6.51), less than Keros Therapeutics, Inc. (20.37), less than Syndax Pharmaceuticals, Inc. (10.50), less than Mineralys Therapeutics, Inc. (11.20), less than Replimune Group, Inc. (13.46), less than Ocular Therapeutix, Inc. (16.64), less than Veracyte, Inc. (4.44), less than Avidity Biosciences, Inc. (15.78), less than SpringWorks Therapeutics, Inc. (7.91), less than Monte Rosa Therapeutics, Inc. (6.56), less than Nkarta, Inc. (15.91), less than Generation Bio Co. (7.42), less than Sana Biotechnology, Inc. (5.20),
Company | Current Ratio | Market cap |
---|---|---|
5.69 | $455.91M | |
60.41 | $342.68M | |
3.41 | $302.45M | |
5.39 | $30.95M | |
16.09 | $5.12B | |
6.20 | $225.10M | |
8.32 | $3.51B | |
16.19 | $325.12M | |
8.49 | $57.28M | |
6.51 | $78.52M | |
20.37 | $2.25B | |
10.50 | $1.61B | |
11.20 | $671.31M | |
13.46 | $821.22M | |
16.64 | $1.60B | |
4.44 | $2.69B | |
15.78 | $5.25B | |
7.91 | $2.30B | |
6.56 | $542.54M | |
15.91 | $227.90M | |
7.42 | $144.16M | |
5.20 | $836.47M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MediWound Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MediWound Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is MediWound Ltd.'s Current Ratio?
How is the Current Ratio calculated for MediWound Ltd. (MDWD)?
What is the highest Current Ratio for MediWound Ltd. (MDWD)?
What is the 3-year average Current Ratio for MediWound Ltd. (MDWD)?
What is the 5-year average Current Ratio for MediWound Ltd. (MDWD)?
How does the current Current Ratio for MediWound Ltd. (MDWD) compare to its historical average?